Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 4, No 2 (2012) Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease Abstract  similar documents
S N Illarioshkin
"... receptor agonists (DRA) remains the leading pharmacotherapeutic strategy for Parkinson’s disease (PD ..."
 
Vol 3, No 1 (2011) Sleep disorders in Parkinson's disease Abstract  similar documents
Marina Romanovna Nodel', Marina Romanovna Nodel
"... of Parkinson's disease (PD). Objective: to specify the clinical features of sleep disorders in patients with PD ..."
 
Vol 6, No 1 (2014) Apathy in Parkinson's disease patients Abstract  similar documents
M. R. Nodel
"... pathy in Parkinson's disease (PD) patients is one of the least studied manifestations of a broad ..."
 
Vol 6, No 3 (2014) Current therapy for Parkinson's disease Abstract  similar documents
A. V. Obukhova
"... The main goal of therapy for Parkinson's disease (PD) is to correct dopamine deficiency ..."
 
Vol 3, No 4 (2011) Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole Abstract  similar documents
Marina Romanovna Nodel
"... Fatigability is a common nonmotor symptom in Parkinson's disease (PD), which worsens quality ..."
 
Vol 4, No 1 (2012) Sustained-release pramipexole in the treatment of Parkinson’s disease Abstract  similar documents
Natalia Vladimirovna Fedorova
"... for dopaminergic deficiency in Parkinson’s disease (PD). Since 1996, pramipexole has been used to treat early ..."
 
Vol 4, No 3 (2012) Clinical experience with requip modutab Abstract  similar documents
Denis Valeryevich Zakharov, V A Mikhailov
"... The efficacy of dopamine receptor agonists (DRAs) is determined by a number of advantages. DRAs ..."
 
Vol 5, No 3 (2013) The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease Abstract  similar documents
Marina Romanovna Nodel
"... Rotigotine is a new, non-ergot dopamine receptor agonist (DRA) formulated as a transdermal drug ..."
 
Vol 5, No 1 (2013) Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease Abstract  similar documents
Oleg Semenovich Levin, V K Datiyeva
"... receptor agonist (DRAs), which has been widely used to treat Parkinson’s disease (PD) in foreign countries ..."
 
Vol 2, No 4 (2010) Depression in Parkinson's disease Abstract  similar documents
Marina Romanovna Nodel', Marina Romanovna Nodel
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a wide spectrum ..."
 
Vol 2, No 3 (2010) Treatment of parkinson's disease ata young age Abstract  similar documents
Dmitry Valeryevich Artemyev
"... and middle-aged patients. It is stressed that early-onset Parkinson's disease (PD) shows a number ..."
 
Vol 4, No 1 (2012) Sleep and awakening disorders in Parkinson’s disease: comprehensive approach to therapy Abstract  similar documents
Marina Romanovna Nodel
"... and awakening disorders in patients with Parkinson’s disease (PD). It covers the current views of the role ..."
 
Vol 1, No 2 (2009) NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE Abstract  similar documents
Marina Romanovna Nodel', N N Yakhno, Marina Romanovna Nodel, N N Yakhno
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease involving different mediator ..."
 
Vol 7, No 3 (2015) Experience in using levodopa-benserazide Abstract  similar documents
Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova
"... Levodopa remains the most effective drug for the treatment of Parkinson's disease. The paper ..."
 
Vol 5, No 1 (2013) Dopamine dysregulation syndrome in Parkinson’s disease Abstract  similar documents
A V Nikitina, Natalia Vladimirovna Fedorova
"... therapy. According to the data available in the literature, DDS develops in 3-4% of the Parkinson’s ..."
 
Vol 8, No 4 (2016) HYPERSOMNIA AND CIRCADIAN DISTURBANCES IN PARKINSON’S DISEASE Abstract  similar documents
M. R. Nodel
"... studied symptoms of Parkinson’s disease (PD). It manifests as constant excessive sleepiness during the day ..."
 
Vol 6, No 4 (2014) Nondrug therapy in the combination rehabilitation of patients with Parkinson’s disease Abstract  similar documents
V. L. Golubev, A. B. Kamakinova
"... Non-drug rehabilitation in Parkinson’s disease (PD) has recently attracted the increasing ..."
 
Vol 5, No 2 (2013) The clinical picture of early-stage Parkinson’s disease. errors in the diagnosis of different forms Abstract  similar documents
E N Gubanova, Natalia Vladimirovna Fedorova
"... The paper describes the clinical picture of Parkinson’s disease (PD), by indicating its stages ..."
 
Vol 9, No 1 (2017) The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease Abstract  similar documents
G. N. Akhmadeeva, R. V. Magzhanov, G. N. Tayupova, A. R. Baitimerov
"... with Parkinson's disease (PD) and gives their characteristics and epidemiology, the specific features ..."
 
Vol 3, No 3 (2011) Neuropsychiatrie disorders in Parkinson's disease and their correction with the MAO-B inhibitor rasagiline (Azilect®) Abstract  similar documents
M R Nodel
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a broad spectrum ..."
 
Vol 3, No 1 (2011) Heart rhythm variability analysis in patients with Levy body dementiaand in those with Parkinson's disease Abstract  similar documents
I G Tishkova, Irina Sergeevna Preobrazhenskaya, I G Tishkova, Irina Sergeyevna Preobrazhenskaya
"... ) and Parkinson's disease (PD). Objective: to analyze autonomic provision of cardiac performance in patients ..."
 
Vol 5, No 2 (2013) Current possibilities of therapy for sleep disorders in Parkinson’s disease Abstract  similar documents
Marina Romanovna Nodel
"... and awakening disorders in patients with Parkinson's disease (PD). It covers the current views of the role ..."
 
Vol 6, No 4 (2014) The epidemiological, clinical, and genetic characteristics of Parkinson’s disease (in case of Zheleznogorsk) Abstract  similar documents
M. R. Sapronova, N. A. Shnaider
"... Parkinson’s disease (PD) is the second most common human neurodegenerative disorder. Genetically ..."
 
Vol 9, No 1 (2017) The genetic basis of Parkinson's disease Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, P. I. Gurieva, N. A. Shnaider, M. M. Petrova, M. R. Sapronova
"... Parkinson's disease (PD) is a multifactorial disease that develops in the presence of both genetic ..."
 
Vol 9, No 4 (2017) Neuropsychological pattern of Parkinson's disease Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova, M. R. Sapronova
"... The review deals with the problem of neuropsychological disorders in Parkinson's disease (PD), one ..."
 
Online-first Features of pathogenesis and clinical manifestation of Parkinson's disease developed from essential tremor Abstract  similar documents
A. V. Kudrevatykh, I. V. Miliukhina
"... In last decades, there is evidence of the relationship of Parkinson's disease (PD) and essential ..."
 
Vol 11, No 2 (2019) Pathogenesis, clinical features, and treatments of depression in Parkinson's disease Abstract  similar documents
I. V. Milyukhina
"... Depression is the most common non-motor manifestation of Parkinson's disease (PD), which ..."
 
Vol 9, No 4 (2017) Sleep disorders in Parkinson’s disease: approaches to treatment and prevention Abstract  similar documents
M. R. Nodel, G. V. Kovrov
"... Nocturnal sleep disorders are one of the most important non-motor manifestations of Parkinson’s ..."
 
Vol 5, No 2 (2013) Neuropsychological syndromes in patients with Parkinson’s disease after deep electric stimulation of pallidar complex structures Abstract  similar documents
Yu V Mikadze, Irina Igorevna Titkova, A O Gushcha, V M Tyurnikov
"... The paper provides the results of neuropsychological examinations in 10 patients with Parkinson’s ..."
 
Vol 9, No 3 (2017) Screening for non-motor symptoms in Parkinson's disease using the NMSQuest scale Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova
"... The clinical picture of Parkinson's disease (PD) includes a wide range of non-motor symptoms (NMS ..."
 
Vol 7, No 4 (2015) Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use Abstract  similar documents
N. V. Trofimova, I. S. Preobrazhenskaya
"... ; neuroprotective effect; sirtuins; Alzheimer’s disease; Parkinson’s disease. Contact: Irina Sergeevna ..."
 
Vol 10, No 4 (2018) Nighttime sleep disorders in patients with daytime sleepiness in Parkinson s disease Abstract  similar documents
M. R. Nodel, K. V. Shevtsova, G. V. Kovrov, N. N. Yakhno
"... Daytime sleepiness is one of the clinically significant non-motor manifestations of Parkinson ..."
 
Vol 10, No 4 (2018) Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease Abstract  similar documents
Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova
"... Motor and non-motor symptoms are identified in the clinical picture of Parkinson's disease (PD ..."
 
Vol 3, No 4 (2011) Individual functional interhemispheric asymmetry profile and clinical and neurophysiological features in patients with Parkinson's disease Abstract  similar documents
Maria Andreyevna Bykanova, A Yu Kovalchuk, N V Pizova, N G Efremenko, A A Kostylev
"... ) in 70 patients (28 men and 42 women) with Parkinson's disease (PD), by using ..."
 
Vol 10, No 2 (2018) Parkinson's disease and polymorphisms of the glutamatergic system genes GRIN2A, SLC1A2, and GRIK4 Abstract  similar documents
Yu. S. Mironova, I. A. Zhukova, N. G. Zhukova, S. A. Ivanova, V. M. Alifirova, A. S. Boiko, D. Z. Osmanova, O. P. Izhboldina, A. V. Latypova
"... Parkinson's disease (PD) is now increasingly considered as a multi-system disorder associated ..."
 
Vol 11, No 2 (2019) Susceptibility-weighted MR imaging (SWI) of basal ganglia iron deposition in the early and advanced stages of Parkinson's disease Abstract  similar documents
A. G. Trufanov, A. A. Yurin, A. B. Buriak, S. A. Sandalov, M. M. Odinak, I. V. Litvinenko
"... Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer ..."
 
Vol 10, No 3 (2018) Familial neurodegenerative disease with parkinsonism syndrome and amyotrophic lateral sclerosis Abstract  PDF (Eng)  similar documents
T. K. Davydova, A. A. Tappakhov, T. E. Popova, E. E. Konnikova, A. D. Alekseeva, D. A. Popov
"... siblings, one of whom is observed to have parkinsonism with ALS syndrome; and the other had Parkinson ..."
 
Vol 5, No 1 (2013) Clinical value of the major types of reactions of the body’s stress-regulating systems in ischemic stroke Abstract  similar documents
Aleksandr Mikhailovich Dolgov, A Yu Ryabchenko
"... .E., Pahwa R. An Open-Label Conversion Study of Pramipexole to Ropinirole Prolonged Release in Parkinson ..."
 
Vol 4, No 2 (2012) Capacities for the drug correction of functional disorders in posthypoxic encephalopathy Abstract  similar documents
M M Odinak, A Yu Emelin, V Yu Lobzin, S V Vorobyev
"... pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease. Mov Diso 2003:18 ..."
 
Vol 4, No 1 (2012) Post-stroke depression: scientifically substantiated approaches to choosing therapy Abstract  similar documents
Yulia Aleksandrovna Starchina
"... al. Pramipexole for the treatment of depressive symptoms in patients with Parkinson’s disease: a ..."
 
Vol 10, No 4 (2018) Approaches to therapy for depressions in neurology: prospects for the use of agomelatine Abstract  similar documents
D. V. Romanov, B. A. Volel, D. S. Petelin
"... of patients with post-stroke depression, Parkinson’s disease, Alzheimer’s disease, Pick’s disease, Huntington ..."
 
Vol 4, No 2 (2012) Strokes in mitochondrial diseases Abstract  similar documents
N V Pizova
"... дофаминовых рецепторов (АДР). Длительное применение леводопы чревато развитием характерных флуктуаций ..."
 
Vol 6, No 2S (2014): Special issue "Stroke" Cognitive reserve and cognitive impairments: drug and nondrug treatments Abstract  similar documents
E.I. Dainikova, N.V. Pizova
"... and Parkinson's disease, are covered. The issues of correcting CIs in cerebrovascular and neurodegenerative ..."
 
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders Cognitive and neuropsychiatric disorders in extrapyramidal diseases Abstract  similar documents
O. S. Levin, M. A. Anikin, E. E. Vasenina
"... of Parkinson’s disease or Huntington’s disease in persons who are predisposed to these diseases. Moreover ..."
 
Vol 10, No 1 (2018) Headache in elderly patients with chronic cerebral ischemia: outpatient diagnosis and treatment Abstract  similar documents
M. P. Platov, O. V. Kosivtsova
"... 's disease, and Parkinson's syndrome, are frequently hidden under the diagnosis of CCI. The leading ..."
 
Vol 2, No 4 (2010) Aprroaches to reducing the cardiovascular risk in the late periods of ischemic stroke Abstract  similar documents
Andrey Viktorovich Fonyakin, L A Geraskina, V A Shandalin, Andrey Viktorovich Fonyakin, L A Geraskina, V A Shandalin
"... достигается с помощью широкого спектра препаратов, включая современные селективные бета-адре- ноблокаторы ..."
 
Vol 8, No 2 (2016) Neuroimmunological mechanisms of chronic pain syndrome Abstract  similar documents
I. A. Vyshlova, S. M. Karpov, A. I. Starodubtsev
"... болевом синдроме происходит ак- тивация симпатико-адреналовой системы. Экскреция адре- налина ..."
 
Vol 4, No 3 (2012) The clinical and psychological features of back pain in children and adolescents Abstract  similar documents
S Yu Anisimova, Andrey Petrovich Rachin
"... was leter added, with Parkinson’s disease: A 5-year follow-up. J Neurol Neurosurg Psychiatry 1994 ..."
 
Vol 3, No 4 (2011) Cognitive functions in patients with stenotic lesions of the great arteries of the head before and after carotid endartectomy Abstract  similar documents
Olga Vladimirovna Gavrilova, L V Stakhovskaya, S B Buklina, D Yu Usachev, V A Lukshin, A Yu Belyaev, V V Akhmetov, V I Skvortsova
"... терапии агонистом дофаминовых рецепторов прамипексолом (мирапекс). Пациенты и методы. Обследовано 60 ..."
 
Vol 4, No 2 (2012) Sleep and memory problems: acetylcholine in some neurodegenerative diseases, use of an extended-release formulation of galantamine Abstract  similar documents
I V Litvinenko
"... ., Leu S., Oudiette D. Abnormal sleep and sleepiness in Parkinson's disease. Curr Opin Neurol 2008;21(4 ..."
 
1 - 50 of 81 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)